FDA ap­proves Ital­far­ma­co’s drug Du­vyzat for Duchenne mus­cu­lar dy­s­tro­phy

The FDA ap­proved the first non­s­teroidal drug to treat all ge­net­ic vari­ants of Duchenne mus­cu­lar dy­s­tro­phy, clear­ing drug­mak­er Ital­far­ma­co’s oral treat­ment for pa­tients age 6 …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER